Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-018751
Filing Date
2020-07-08
Accepted
2020-07-08 17:37:52
Documents
2
Period of Report
2020-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1591
2 EX-24 DOCUMENT attachment1.htm EX-24 4747
  Complete submission text file 0000899243-20-018751.txt   7827
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Issuer) CIK: 0001501134 (see all company filings)

EIN.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address
Knight Kenneth D. (Reporting) CIK: 0001817388 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36847 | Film No.: 201019050